We partnered with the Edgewood Health Network (EHN) to conduct a four month pilot study to explore Wagon’s overall impact and effectiveness for clients. Participants ranged from 26-59 years old. Gender of participants was relatively equal; 56.8% were male, while 43.2% were female. Participants were selected from multiple EHN programs including extended care (35.5%), in-person continuing care (32.3%), online continuing care (16.1%) and individual therapy (16.1%). The primary reported addiction was alcohol (40.5%), followed by alcohol and drugs (35.1%), drugs (21.6%), and other (2.7%). In addition, 51.4% of participants reported having one or more process addictions in combination with their substance addiction.
67% of participants reported that triggers decreased while using Wagon
27% of participants reported that their triggers stayed the same while using Wagon
11% of participants reported that their triggers increased while using Wagon
47% of participants reported a decrease in isolation while using Wagon.
Comments from participants indicated that Wagon prompted them to reflect on whether they were isolating or not, reminded them not to isolate and that their goals were designed to prevent isolation.
64% of participants reported an increased in happiness while using Wagon.
Comments from participants indicated that they felt happy when they saw positive progress, and that the felt happier knowing a counsellor was checking on them.
54% of participants reported that Wagon helped them maintain abstinence.
Comments from participants mentioned that Wagon reminded them of their recovery each day. For those that did indicate a relapse, 75% felt that Wagon helped them get back on track.
Supported a Recovery Plan
86% of participants reported that Wagon helped them follow their recovery plan.
Comments from participants indicated that the support they received from their counsellor was personalized and kept them accountable.
Recommended by Patients
73% of participants reported that they would recommend Wagon to others struggling with substance use disorders.
Comments from participants indicated that Wagon served as a recovery toolkit that helped them focus on their goals.
Beginning in January 2018, we will follow a patients participating in an IOP (Intensive Outpatient Program) at Edgewood Health Network clinics across Canada. We are targeting 150 patients and plan to follow them for 120 days. A large control group will be used to measure the effectiveness of Wagon. This research will be led by Dr. Christina Basedow.